Ralimetinib
- Generic Name
- Ralimetinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H29FN6
- CAS Number
- 862505-00-8
- Unique Ingredient Identifier
- 73I34XW4HD
- Background
Ralimetinib has been used in trials studying the treatment of Postmenopausal, Advanced Cancer, Adult Glioblastoma, Fallopian Tube Cancer, and Metastatic Breast Cancer, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath